Yes, Hankmanhub, only one cancer with Direct. I thought I heard that but didn't go back to check. The important addition, (I think is new), is that this trial and much of the other stuff they mentioned, is ready to go. Just waiting for the approval all us longs expect. The ASM was very, very bullish for the stuff on their plate. Just waiting for MHRA to finish up.
Market Data 
Markets 
AI
